The latest global regulatory news, changes and updates affecting biopharma, including: Alkermes, Amarin, Gilead, McKesson, Novartis, Oncolix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aeon, Cytodyn, Innovent, Nippon Shinyaku.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allergy, AMRI, Astrazeneca, Biocryst, CNS, Deepvax, Diurnal, Enesi, Gilead, Geovax, Ionis, Pharnext, Redhill, Saliba, Vistagen, Xencor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 89bio, Akebia, Auris, Bio-Thera, Celecor, Exact, GSK, Hutchison China Meditech, Incyte, Lattice, Madrigal, Novan, Novavax, Octapharma, Sanofi, Sutro, Tonix.

It turns out that determining who gets a COVID-19 vaccine first can be nearly as challenging as developing the vaccine itself. The timeline is a big part of the challenge.

The latest global regulatory news, changes and updates affecting biopharma, including: Abbvie.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dompé, Mesoblast, Mustang, Oblato, Pharmacyte.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AB Science, Amgen, Asklepios, Binex, Biomx, Boehringer, Brickbio, City of Hope, Clene, Decode, Enosi, Evotec, Harbour, Highlight, Idorsia, Igyxos, Körber, Lyell, Magenta, Menlo, Merck, Oncimmune, Orca, Parnell, Pharmabcine, Preveceutical, Reveragen, Revive, Santhera, Selexis, Sorrento, Sunesis, Twist, Vyne, Walvax.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Aerpio, Algernon, Bicycle, Janssen, Nicox, Nocion, Poxel, Rocket, SAB, Tetra Bio-Pharma, Treadwell, X4.